# OnCo record nectin4 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/nectin4/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "nectin4" ;
  schema:name "Nectin-4"@en ;
  schema:description "Nectin-4 is an adhesion protein plentiful on bladder cancer cells, used as the docking site for the ADC enfortumab vedotin."@en ;
  schema:url <https://onco.cc/targets/nectin4/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Nectin-4>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:19688>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143217>, <https://www.uniprot.org/uniprotkb/Q96NY8/entry>, <https://www.ncbi.nlm.nih.gov/gene/81607> ;
  schema:citation <https://en.wikipedia.org/wiki/Nectin-4> ;
  onco:tag "adc-target" ;
  schema:alternateName "NECTIN4" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "2001"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/nectin-4-expression/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/tnbc/> ;
  onco:drugs <https://onco.cc/drugs/crb-701/> ;
  onco:companies <https://onco.cc/companies/emergence-therapeutics/>, <https://onco.cc/companies/marengo-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07299747/> .